Literature DB >> 24906952

Lipopolysaccharide binding protein, obesity status and incidence of metabolic syndrome: a prospective study among middle-aged and older Chinese.

Xin Liu1, Ling Lu, Pang Yao, Yiwei Ma, Feijie Wang, Qianlu Jin, Xingwang Ye, Huaixing Li, Frank B Hu, Liang Sun, Xu Lin.   

Abstract

AIMS/HYPOTHESIS: Although microbiota-derived endotoxaemia has previously been shown to induce metabolic disorders, data from population-based longitudinal studies are scarce. This study therefore investigated the associations between lipopolysaccharide binding protein (LBP) levels and 6 year incident metabolic syndrome (MetS), as well as the potentially modifying effects of obesity status in middle-aged and older Chinese men and women.
METHODS: A total of 2,529 men and women aged 50-70 years from Beijing and Shanghai, China, were followed for 6 years. Those free of MetS at baseline (1,312) were included in the analyses for the risk of developing MetS. Baseline plasma LBP was measured using an ELISA kit.
RESULTS: During the 6 year follow-up, 449 (34.2%) participants developed MetS. Baseline LBP was significantly associated with BMI, waist circumference, blood lipid profile and C-reactive protein (CRP) both at baseline and during follow-up (all p < 0.05). The RR for incident MetS comparing extreme quartiles of LBP was 1.28 (95% CI 1.04, 1.58), after multivariate adjustment including BMI and CRP. In stratified analysis, LBP was positively associated with incident MetS only in normal-weight participants (RR, comparing extreme tertiles, 1.59; 95% CI 1.18, 2.15; p(trend)= 0.002), but not in their overweight/obese counterparts (RR, comparing extreme tertiles, 0.99; 95% CI 0.80, 1.22; p(trend) = 0.880). A significant interaction was observed between LBP and obesity status (p(interaction) = 0.013). CONCLUSIONS/
INTERPRETATION: Our study suggested that elevated plasma LBP was associated with an increased risk of developing MetS among middle-aged and older Chinese, especially in normal-weight individuals.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24906952     DOI: 10.1007/s00125-014-3288-7

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  30 in total

1.  Associations of erythrocyte fatty acids in the de novo lipogenesis pathway with risk of metabolic syndrome in a cohort study of middle-aged and older Chinese.

Authors:  Geng Zong; Jingwen Zhu; Liang Sun; Xingwang Ye; Ling Lu; Qianlu Jin; He Zheng; Zhijie Yu; Zhenni Zhu; Huaixing Li; Qi Sun; Xu Lin
Journal:  Am J Clin Nutr       Date:  2013-06-26       Impact factor: 7.045

2.  A metagenome-wide association study of gut microbiota in type 2 diabetes.

Authors:  Junjie Qin; Yingrui Li; Zhiming Cai; Shenghui Li; Jianfeng Zhu; Fan Zhang; Suisha Liang; Wenwei Zhang; Yuanlin Guan; Dongqian Shen; Yangqing Peng; Dongya Zhang; Zhuye Jie; Wenxian Wu; Youwen Qin; Wenbin Xue; Junhua Li; Lingchuan Han; Donghui Lu; Peixian Wu; Yali Dai; Xiaojuan Sun; Zesong Li; Aifa Tang; Shilong Zhong; Xiaoping Li; Weineng Chen; Ran Xu; Mingbang Wang; Qiang Feng; Meihua Gong; Jing Yu; Yanyan Zhang; Ming Zhang; Torben Hansen; Gaston Sanchez; Jeroen Raes; Gwen Falony; Shujiro Okuda; Mathieu Almeida; Emmanuelle LeChatelier; Pierre Renault; Nicolas Pons; Jean-Michel Batto; Zhaoxi Zhang; Hua Chen; Ruifu Yang; Weimou Zheng; Songgang Li; Huanming Yang; Jian Wang; S Dusko Ehrlich; Rasmus Nielsen; Oluf Pedersen; Karsten Kristiansen; Jun Wang
Journal:  Nature       Date:  2012-09-26       Impact factor: 49.962

3.  Inducible nitric oxide synthase plays a role in LPS-induced hyperglycemia and insulin resistance.

Authors:  Hiroki Sugita; Masao Kaneki; Eriko Tokunaga; Michiko Sugita; Chieko Koike; Shingo Yasuhara; Ronald G Tompkins; J A Jeevendra Martyn
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-02       Impact factor: 4.310

4.  Associations of erythrocyte palmitoleic acid with adipokines, inflammatory markers, and the metabolic syndrome in middle-aged and older Chinese.

Authors:  Geng Zong; Xingwang Ye; Liang Sun; Huaixing Li; Zhijie Yu; Frank B Hu; Qi Sun; Xu Lin
Journal:  Am J Clin Nutr       Date:  2012-09-26       Impact factor: 7.045

5.  Obesity and IL-6 interact in modulating the response to endotoxemia in mice.

Authors:  Maria Pini; Karla J Castellanos; Davina H Rhodes; Giamila Fantuzzi
Journal:  Cytokine       Date:  2012-09-23       Impact factor: 3.861

6.  Development of hypertriglyceridemia in patients with enterocutaneous fistulas.

Authors:  Ruben G J Visschers; Steven W M Olde Damink; Malou Schreurs; Bjorn Winkens; Peter B Soeters; Wim G van Gemert
Journal:  Clin Nutr       Date:  2009-03-26       Impact factor: 7.324

Review 7.  The gut microbiota and obesity: from correlation to causality.

Authors:  Liping Zhao
Journal:  Nat Rev Microbiol       Date:  2013-08-05       Impact factor: 60.633

8.  Hyperglycemia in sepsis is a risk factor for development of type II diabetes.

Authors:  Ivan Gornik; Ana Vujaklija; Edita Lukić; Goran Madzarac; Vladimir Gasparović
Journal:  J Crit Care       Date:  2009-11-14       Impact factor: 3.425

9.  Does chronic low-grade endotoxemia define susceptibility of obese humans to insulin resistance via dietary effects on gut microbiota?

Authors:  Daniel M Kemp
Journal:  Adipocyte       Date:  2013-04-23       Impact factor: 4.534

10.  Determinants of serum concentrations of lipopolysaccharide-binding protein (LBP) in the adult population: the role of obesity.

Authors:  Arturo Gonzalez-Quintela; Manuela Alonso; Joaquin Campos; Luis Vizcaino; Lourdes Loidi; Francisco Gude
Journal:  PLoS One       Date:  2013-01-22       Impact factor: 3.240

View more
  32 in total

1.  Nonalcoholic fatty liver disease as trigger of cardiovascular and metabolic complication in metabolic syndrome.

Authors:  Luca Miele; Giovanni Gasbarrini; Valentina Giorgio; Antonio Gasbarrini; Antonio Grieco
Journal:  Intern Emerg Med       Date:  2015-11-24       Impact factor: 3.397

Review 2.  Emerging risk biomarkers in cardiovascular diseases and disorders.

Authors:  Ravi Kant Upadhyay
Journal:  J Lipids       Date:  2015-04-08

Review 3.  The gut microbiota modulates both browning of white adipose tissue and the activity of brown adipose tissue.

Authors:  José María Moreno-Navarrete; José Manuel Fernandez-Real
Journal:  Rev Endocr Metab Disord       Date:  2019-12       Impact factor: 6.514

4.  Association of Lipopolysaccharide-Binding Protein With Aging-Related Adiposity Change and Prediabetes Among African Ancestry Men.

Authors:  Curtis M Tilves; Joseph M Zmuda; Allison L Kuipers; Cara S Nestlerode; Rhobert W Evans; Clareann H Bunker; Alan L Patrick; Iva Miljkovic
Journal:  Diabetes Care       Date:  2015-12-30       Impact factor: 19.112

Review 5.  Metabolic endotoxemia with obesity: Is it real and is it relevant?

Authors:  Nabil E Boutagy; Ryan P McMillan; Madlyn I Frisard; Matthew W Hulver
Journal:  Biochimie       Date:  2015-06-29       Impact factor: 4.079

6.  Neuroinflammation in obesity: circulating lipopolysaccharide-binding protein associates with brain structure and cognitive performance.

Authors:  J M Moreno-Navarrete; G Blasco; J Puig; C Biarnés; M Rivero; J Gich; F Fernández-Aranda; J Garre-Olmo; L Ramió-Torrentà; Á Alberich-Bayarri; F García-Castro; S Pedraza; W Ricart; J M Fernández-Real
Journal:  Int J Obes (Lond)       Date:  2017-07-07       Impact factor: 5.095

7.  Lipopolysaccharide-binding protein is a negative regulator of adipose tissue browning in mice and humans.

Authors:  Aleix Gavaldà-Navarro; José M Moreno-Navarrete; Tania Quesada-López; Montserrat Cairó; Marta Giralt; José M Fernández-Real; Francesc Villarroya
Journal:  Diabetologia       Date:  2016-06-25       Impact factor: 10.122

8.  Plasma lipopolysaccharide binding protein level statistically mediates between body mass index and chronic microinflammation in Japanese patients with type 1 diabetes.

Authors:  Hirotaka Watanabe; Takashi Katsura; Mitsuyoshi Takahara; Kazuyuki Miyashita; Naoto Katakami; Taka-Aki Matsuoka; Dan Kawamori; Iichiro Shimomura
Journal:  Diabetol Int       Date:  2020-03-09

9.  Higher Lipopolysaccharide Binding Protein and Chemerin Concentrations Were Associated with Metabolic Syndrome Features in Pediatric Subjects with Abdominal Obesity during a Lifestyle Intervention.

Authors:  Amelia Marti; Isabel Martínez; Ana Ojeda-Rodríguez; María Cristina Azcona-Sanjulian
Journal:  Nutrients       Date:  2021-01-20       Impact factor: 5.717

Review 10.  Effects of Lipopolysaccharide-Binding Protein (LBP) Single Nucleotide Polymorphism (SNP) in Infections, Inflammatory Diseases, Metabolic Disorders and Cancers.

Authors:  Leilei Meng; Zichen Song; Anding Liu; Uta Dahmen; Xiao Yang; Haoshu Fang
Journal:  Front Immunol       Date:  2021-07-06       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.